Skip to main content
Shree Ganesh Biotech (India) Limited logo

Shree Ganesh Biotech (India) Limited — Investor Relations & Filings

Ticker · 539470 ISIN · INE051N01026 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 539470

About Shree Ganesh Biotech (India) Limited

https://shreeganeshbiotech.shop/

Shree Ganesh Biotech (India) Limited specializes in the production, processing, and marketing of high-quality hybrid seeds. The company focuses on agricultural biotechnology to develop seeds that offer improved yields and resistance to environmental stressors. Its product portfolio includes a diverse range of hybrid seeds for cereals such as maize, bajra, and paddy, as well as various vegetable seeds. By leveraging research and development, the company aims to provide farmers with advanced agricultural solutions that enhance productivity and crop quality. The organization maintains a focus on seed technology to support sustainable farming practices and meet the evolving demands of the agricultural sector.

Recent filings

Filing Released Lang Actions
PFA
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report issued by a Practicing Company Secretary under SEBI LODR Regulation 24A, addressed to stock exchanges. It is a compliance certificate/attestation rather than a full annual or quarterly financial report, earnings release, or management discussion. It does not contain financial statements, proxy materials, or voting results, but certifies regulatory compliance. It thus falls under the fallback category for general regulatory announcements and compliance documents: Regulatory Filings (RNS).
2026-05-23 English
PFA
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure letter filed under SEBI (LODR) Regulation 32(1), informing exchanges about the non‐utilisation of issue proceeds and stating no Annexure is required. It is a compliance/regulatory announcement rather than a financial report, earnings release, management presentation, or other specific category. Therefore, it falls under the general “Regulatory Filings (RNS)” category.
2026-05-14 English
PFA
Interim / Quarterly Report Classification · 85% confidence The document is the Company’s Audited Financial Results for the quarter and year ended 31 March 2026 submitted under SEBI Listing Regulation 33. It includes standalone financial statements (statement of profit & loss, assets & liabilities, cash flows) and the Independent Auditor’s Report. This is a periodic financial report rather than a full narrative Annual Report (10-K) or just an audit opinion. It aligns with our definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-14 English
This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) ....
Audit Report / Information Classification · 92% confidence The document is a formal audited financial results disclosure under SEBI Listing Regulations which includes the full audited standalone financial statements (P&L, balance sheet, cash flow statement, notes) along with an Independent Auditor’s Report. It is not merely an announcement of an upcoming report, nor a short earnings release, and it contains substantive audited financial data. This aligns with the “Audit Report / Information (AR)” category, which covers standalone audit reports and applied accounting principles (excluding full narrative Annual Reports).
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.